by rss feed | Oct 13, 2026 | News Feeds
Mursla Bio, a precision medicine and diagnostics company built on tissue-specific extracellular vesicles (TS-EVs), today announced publication of a peer-reviewed study in the Journal of Extracellular Vesicles (impact factor 21.7), the founding journal of the...
by rss feed | Oct 13, 2026 | News Feeds
Mursla Bio, a precision medicine and diagnostics company built on tissue-specific extracellular vesicles (TS-EVs), today announced publication of a peer-reviewed study in the Journal of Extracellular Vesicles (impact factor 21.7), the founding journal of the...
by rss feed | Oct 13, 2026 | News Feeds
Through Bioz Badges, Yokogawa transforms its extensive publication history into a valuable resource for researchers evaluating advanced microscopy technologies. Read Original...
by rss feed | Oct 13, 2026 | News Feeds
We are pleased to announce the appointment of Dr Adrijana Vinter as Chief Executive Officer. Dr Vinter brings more than 20 years of experience spanning medicinal chemistry research, commercial development and executive leadership in the pharmaceutical and contract...
by rss feed | Oct 13, 2026 | News Feeds
In a phase 1 study of 10 adults with advanced retinitis pigmentosa, researchers found that optogenetic gene therapy combined with light-stimulating goggles was generally well tolerated, although one participant experienced a severe but transient ocular adverse event....
